Table 2 Risk of Metabolic syndrome and its components may modify by circulating PPARγ in the obese subjects

Metabolic syndrome‡

Model 1‖

1.85

1.07-3.20

0.02

Model 2¶

2.05

1.14-3.67

0.01

Model 3†

1.90

1.04-3.47

0.03

Model 4§

1.88

1.01-3.49

0.04

Abdominal Obesity (WC)

Model 1

3.889

1.49-10.14

0.005

Model 2

5.069

1.66-15.43

0.004

Model 3

4.820

1.30-17.75

0.018

Model 4

5.199

1.07-25.26

0.04

Hyperglycemia*

Model 1

1.47

0.77-2.79

0.23

Model 2

1.55

0.80-2.99

0.18

Model 3

1.42

0.71-2.81

0.31

Model 4

1.39

0.67-2.88

0.37

Hypertension

Model 1

1.22

0.71-2.10

0.46

Model 2

1.49

0.71-3.14

0.28

Model 3

1.33

0.62-2.87

0.46

Model 4

1.15

0.51-2.61

0.72

Low HDL

Model 1

1.70

0.96-3.02

0.06

Model 2

1.71

0.95-3.06

0.07

Model 3

1.63

0.90-2.95

0.10

Model 4

1.62

0.89-2.95

0.11

Hypertriglyceridemia

Model 1

1.636

0.933-2.869

0.086

Model 2

1.706

0.957-3.042

0.070

Model 3

1.593

0.884-2.870

0.121

Model 4

1.545

0.84-2.83

0.16